Comprehensive Protocol for the Identification and Characterization of New Psychoactive Substances in the Service of Law Enforcement Agencies

被引:10
作者
Bulska, Ewa [1 ]
Bachlinski, Robert [2 ]
Cyranski, Michal K. [1 ]
Michalska-Kacymirow, Magdalena [1 ]
Kosnik, Wioletta [1 ]
Malecki, Pawel [1 ]
Grela, Karol [1 ]
Dobrowolski, Michal A. [1 ]
机构
[1] Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, Warsaw, Poland
[2] Cent Forens Lab Police, Warsaw, Poland
关键词
new psychoactive substance (NPS); synthetic cannabinoid (SC); X-ray diffraction; ES Q; TOF MS; MS; LC-Q; TOF; RECEPTOR; IMPURITIES; INDOLES; ANALOGS; DRUGS;
D O I
10.3389/fchem.2020.00693
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A non-routine, comprehensive protocol for characterization of emerging new psychoactive substances (NPS) including chemical structures, impurities, as well as crystal structures, has been developed to facilitate the work of law enforcement agencies. A set of NPS has been synthesized, identified, and characterized by various analytical methods in order to be used as certified reference standards (CRMs). Seven selected compounds (5-IT, NM-2201, MT-45, AB-CHMINACA, UR-144, 5F-PB-22, and 4-CMC) were synthesized on the laboratory scale, then the process was upscaled to semi-technical. All products were analyzed by electrospray Q/TOF-MS/MS for molecular structure identification. The presence of by-products, as well as metal impurities, arising from the performed syntheses, were characterized by reversed phase liquid chromatography (RP-HPLC) with DAD and Q/TOF-MS detection and inductively-coupled plasma with quadrupole mass spectrometer (ICP-QMS), respectively. Additionally, the crystal structures of UR-144, NM-2201, 5F-PB-22, and 4-CMC have been determined by single-crystal and powder X-ray diffraction.
引用
收藏
页数:12
相关论文
共 35 条
[1]  
[Anonymous], 2012, SADABS
[2]  
[Anonymous], 2019, EU Drug Markets Report
[3]  
[Anonymous], 2013, SAINT
[4]   The use of HPLC-Q-TOF-MS for comprehensive screening of drugs and psychoactive substances in hair samples and several "legal highs" products [J].
Aszyk, Justyna ;
Kot-Wasik, Agata .
MONATSHEFTE FUR CHEMIE, 2016, 147 (08) :1407-1414
[5]  
BAK A, 2019, INT J MOL SCI, V0020
[6]   Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135 [J].
Banister, Samuel D. ;
Stuart, Jordyn ;
Kevin, Richard C. ;
Edington, Amelia ;
Longworth, Mitchell ;
Wilkinson, Shane M. ;
Beinat, Corinne ;
Buchanan, Alexandra S. ;
Hibbs, David E. ;
Glass, Michelle ;
Connor, Mark ;
McGregor, Iain S. ;
Kassiou, Michael .
ACS CHEMICAL NEUROSCIENCE, 2015, 6 (08) :1445-1458
[7]   The Synthesis and Pharmacological Evaluation of Adamantane-Derived Indoles: Cannabimimetic Drugs of Abuse [J].
Banister, Samuel D. ;
Wilkinson, Shane M. ;
Longworth, Mitchell ;
Stuart, Jordyn ;
Apetz, Nadine ;
English, Katrina ;
Brooker, Lance ;
Goebe, Catrin ;
Hibbs, David E. ;
Glass, Michelle ;
Connor, Mark ;
McGregor, Lain S. ;
Kassiou, Michael .
ACS CHEMICAL NEUROSCIENCE, 2013, 4 (07) :1081-1092
[8]  
Bruker, 2013, APEX2
[9]  
COMPTON DR, 1992, J PHARMACOL EXP THER, V260, P201
[10]   Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor [J].
Deng, HF ;
Gifford, AN ;
Zvonok, AM ;
Cui, GJ ;
Li, XY ;
Fan, PS ;
Deschamps, JR ;
Flippen-Anderson, JL ;
Gatley, SJ ;
Makriyannis, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (20) :6386-6392